Growth Metrics

Indivior Pharmaceuticals (INDV) Change in Inventory (2022 - 2026)

Indivior Pharmaceuticals has reported Change in Inventory over the past 5 years, most recently at $1.0 million for Q1 2026.

  • For Q1 2026, Change in Inventory rose 120.0% year-over-year to $1.0 million; the TTM value through Mar 2026 reached -$12.0 million, down 209.09%, while the annual FY2025 figure was -$18.0 million, 141.86% down from the prior year.
  • Change in Inventory for Q1 2026 was $1.0 million at Indivior Pharmaceuticals, up from -$2.0 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $52.0 million in Q4 2022 and troughed at -$17.0 million in Q2 2025.
  • A 5-year average of $4.8 million and a median of $1.0 million in 2026 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: soared 640.0% in 2024 and later crashed 312.5% in 2025.
  • Year by year, Change in Inventory stood at $52.0 million in 2022, then plummeted by 38.46% to $32.0 million in 2023, then crashed by 93.75% to $2.0 million in 2024, then crashed by 200.0% to -$2.0 million in 2025, then soared by 150.0% to $1.0 million in 2026.
  • Business Quant data shows Change in Inventory for INDV at $1.0 million in Q1 2026, -$2.0 million in Q4 2025, and $6.0 million in Q3 2025.